Salute e Benessere
Curaleaf International Launches a Range of Medical Cannabis Products in Australia
Over the coming months, patients and healthcare professionals in Australia can look forward to a broader portfolio and further innovative solutions offered by Curaleaf, including precision-dosed inhalation formats and popular strains already widely prescribed across the UK, Germany , and other key European markets.
Juan Martinez , Head of Curaleaf International, commented: "Entering the Australian market is a significant milestone in our global strategy to expand access to high-quality, evidence-backed cannabis medicines. We're committed to supporting Australian patients and healthcare professionals with reliable, consistent products and the backing of one of the industry's most advanced supply chains."
Boris Jordan , Chairman and CEO of Curaleaf, added: " Australia is an exciting and rapidly evolving market, expected to surpass $1 billion in annual sales next year, and this launch is a positive step forward in our strategy to extend our position as the global leader in cannabis. We're bringing a proven portfolio and a strong track record of innovation, with more to come."
Curaleaf International is shaping the future of cannabis through its commitment to research and product excellence. Powered by a strong presence at all stages of the supply chain, its unique distribution network throughout
Europe , Canada and Australasia brings together pioneering research with cutting-edge cultivation, extraction, and production. Amidst a rapid growth trajectory, the emphasis on quality and expertise aims to ensure the delivery of safe and legal cannabis.
Curaleaf International's network includes a clinic, pharmacy, and laboratory in the UK; cultivation and EU-GMP processing facilities in Portugal ; an EU-GMP processing, quality assurance and research site in Spain ; Four20 Pharma wholesaler and distributor in Germany ; a Polish wholesaler and clinic; and the EU-GMP producer Northern Green Canada.
Curaleaf International is part of Curaleaf Holdings, Inc., a leading international producer and distributor of consumer cannabis products.
Curaleaf International:
Beth Sweet-Escott
Head of Communications, Curaleaf International
media@curaleafint.com
Logo - https://mma.prnewswire.com/media/2538456/Curaleaf_International_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/curaleaf-international-launches-a-range-of-medical-cannabis-products-in-australia-302456544.html